NewsRx

Search our medical news database

Cancer Law Weekly

Susan Hasty, Publisher

Table of Contents . . . July 9th, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Law Weekly | Other Publications

Aphton Corporation - Biotech company appoints Manfred Ruediger as chief operating officer

Avantogen - European patent grant for immune-enhancing adjuvant

Cel-Sci Corp. - U.S. patent allowed on pre-sensitizing cancer prior to treatment

European Society for Human Genetics - Geneticists oppose singling out Jewish women in European patent

Exelixis, Inc. - Collaboration to focus on therapeutics for cancer, inflammation, tissue repair

Kosan Biosciences - Trial of second-generation Hsp90 inhibitor in hematologic cancers initiated

Lorus Therapeutics Inc. - European Patent Office grants patent allowance to protect anticancer drug

North Carolina Cancer Ctr. - Exposure to sunlight may decrease risk of prostate cancer

Theragenics Corporation - Cancer device companies announce settlement of arbitration by mutual consent

University of Edinburgh - Doctors argue for new ways to resolve health treatment choices

AVI BioPharma, Inc. - Positive results reported with Neugene antisense drugs

Abbott - Data reveals a promising new approach in cancer

Affymax, Inc. - Hematide clinical results demonstrate potent effect on red blood cell production

Aichi Medical School - Follicular thyroid carcinoma distinguished from adenoma

Allgemeines Krankenhaus Altona - Radiofrequency ablation with osteoplasty can resolve pain

Antigenics, Inc. - Oncophage cancer vaccine gets European orphan drug designation

Antisoma - Agreement signed to manufacture AS1410 for clinical trials

Ariad Pharmaceuticals, Inc. - Company recognized for development of sarcoma treatment

Ascend Therapeutics - Study of 4-hydroxytamoxifen gel published in Journal of Clinical Oncology

Aston University, West Midlands - Findings advance knowledge in pulmonary medicine research

AstraZeneca - Tyrosine kinase inhibitor AZD2171 subdues tumor angiogenesis

Baylor College Med, Houston - Inducible caspase and interleukin-12 combine well to fight prostate cancer

Bioenvision - Clofarabine active in a broad range of hematologic cancers

Bridgeport Hospital - Researchers' findings advance breast cancer research

Brigham & Women's Hospital - Conditions predisposing to anti-MUC1 antibodies protect against ovarian cancer

Case Western Reserve University, Cleveland - Tumor cells take up tailor-made self-assembled polyelectrolyte shells

Cedara Software Corp. - Cedara B-CAD receives U.S. FDA 510(k) clearance

Cedars-Sinai Med. Ctr. - Chemotherapy for brain tumors is boosted after vaccine

Celgene Corporation - REVLIMID new drug application accepted for review by FDA

Cell Genesys Inc. - Findings describe new data in cancer vaccines research

Center Antoine Lacassagne, Nice - Therapeutic options and pattern of local failure after radiotherapy reported

Center Hospitalier de l'Universite de Montreal - Nomogram predicting outcome of prostate biopsy developed

Center Hospitalier de l'Universite de Vaudois - Apoplexy in pituitary macroadenoma described

Centre Hospitalier Intercommunal, Poissy - Pancreatogastrostomy compared to pancreatojejunostomy

Chaim Sheba Medical Center - Multiple subclones identified in TEL-AML1 at diagnosis

Chiba University - Aberrant expression of RAB1A seen in human tongue cancer

Chicago Prostate Cancer Center - New targeted treatment for prostate cancer available in Chicago

Children's Hospital, Cincinnati - Real-time testing distinguishes SYT-SSX rearrangements in synovial sarcomas

Chinese Academy of Sciences, Shanghai - Researchers publish new studies and findings in the area of diagnostics

Cleveland Clinic Foundation - Eruptive nevi of the palms and soles described

Columbia University, New York - Recent findings in cancer screening provide new insights

Columbus Children's Hospital - Selective target can suppress tumor growth

Cooper Institute, Dallas - Diet and exercise reduce migration inhibitory factor in obese subjects

Cross Cancer Institute, Edmonton - Radiation oncology emerging as Canada's premier career choice

Curis, Inc. - Company doses first patient in phase I clinical trial for basal cell carcinoma

Dartmouth Medical School - New advances may slow tumor growth in pancreatic cancer

EMD Lexigen Research Center Corp. - Anti-CD20-IL-2 immunocytokine efficacious in model of human B lymphoma

EXACT Sciences Corp. - Collaboration to evaluate the performance of certain gene methylation markers

European Institute of Oncology, Milan - Cancer immunotherapy based on killing Salmonella-infected tumors

Evanston Northwestern Healthcare, Chicago - Minimally important differences enhanced interpretability of HRQOL scores

Free University of Brussels - Gene-modified dendritic cells from cancer patients activate CTL clones

Fukuoka University - Researchers describe findings in breast cancer studies

GammaCan International, Inc. - Vered Caplan named acting CEO of immunotherapy maker

Genaissance Pharmaceuticals, Inc. - DNA-focused pharma to provide pharmacogenetic support to INC Research

German Cancer Research Center - A new vector system eases DMBT1 variant and full-length cloning

German Cancer Research Center - Red meat found to elevate, fish to lower colorectal cancer risk

German Cancer Research Center, Heidelberg - Steroid receptor function sways glucocorticoid-mediated immunosuppression

Harvard Medical School - New regulators of apoptosis and chemoresistance identified

Harvard University - Basal epithelial phenotype is more frequent in interval breast cancers

Hiroshima University - Apparent diffusion coefficient used to differentiate human brain tumors with MRI

Hokkaido College of Pharmacy - Pharmaceutical management of patients during lung cancer chemotherapy advised

Hospital Clinic University of Santiago - Doppler ultrasonography assessed tumor necrosis after PEI

Huazhong University of Science & Technology - DNA vaccine plus IL-12 enhances anti-angiogenic and antitumor effects

IMPAC Medical Systems, Inc. - IMPAC supports Varian 4D integrated treatment console

Introgen Therapeutics, Inc. - Introgen continues to advance INGN 007 for the treatment of cancer

Introgen Therapeutics, Inc. - Introgen's INGN 241 effective against multiple cancers in preclinical studies

Introgen Therapeutics, Inc. - Research on apoptosis in cancer cell discussed

Istanbul University - Endoscopic and radiologic interventions cited as leading causes of cholangitis

Johns Hopkins Medical Institute - Unexpected additional primary malignancies detected with PET/CT

Kanazawa University, Ishikawa - Ephrin-A1 causes poor outcomes in alpha-fetoprotein-producing liver cancer

Kanazawa University, Ishikawa - Prostaglandin biosynthetic pathway markers augment lung cancer angiogenesis

Kanazawa University, Ishikawa - Researchers provide details of new studies and findings in the area of enzymology

Krankenhaus der Elisabethinen, Linz - Early lymph node metastases in prostate cancer detected by SLND

Leiden University - Risk of osteoarthritis associated with high production of interleukin

M.D. Anderson Cancer Center - Adjuvant chemotherapy employed in completely resected non-small-cell lung cancer

M.D. Anderson Cancer Center - Research add new data to gene silencing body of knowledge

Max Planck Institute Biochemistry, Martinsried - Functional epigenomics identifies genes frequently silenced in prostate cancer

iCAD, Inc. - CAD detection systems provider partners for resale of fee-for-procedure product

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook